期刊文献+

桥本甲状腺炎患者外周血单个核细胞程序性死亡因子5的表达及其意义 被引量:1

Expression of PDCD5 in Peripheral Blood Monocytes of Patients with Hashimoto's Thyroiditis
下载PDF
导出
摘要 目的探讨程序性死亡因子5(PDCD5)在桥本甲状腺炎(HT)患者外周血单个核细胞(PBMC)中的表达及其与HT发生发展之间的关系。方法选取华北煤炭医学院附属医院2006年3—8月内分泌门诊或住院HT患者60例(HT组)及同期体检健康者40例(对照组)。并根据HT患者血清抗甲状腺微粒体抗体(TMAb)水平,将HT组患者分为HT1组(TMAb≤45%)36例和HT2组(TMAb>45%)24例。采用半定量逆转录聚合酶链反应(RT-PCR)方法测定HT组和对照组受检者PBMC PDCD5 mRNA的表达水平,然后比较HT1组和HT2组患者甲状腺功能、血清甲状腺球蛋白抗体(TGAb)水平及PBMC PDCD5 mRNA表达水平。结果 (1)HT组患者PBMC PDCD5mRNA表达阳性率及相对表达水平均高于对照组〔86.7%(52/60)与60.0%(24/40),(0.87±0.19)与(0.38±0.08)〕,差异有统计学意义(χ2=9.355,t=4.870,P均<0.01)。(2)HT2组患者血清TGAb水平及PBMC PDCD5mRNA表达水平均高于HT1组〔(75.1±18.9)%与(50.4±10.7)%,(1.02±0.08)与(0.60±0.12)〕,差异有统计学意义(t值分别为6.400和15.041,P均<0.01)。结论 HT患者PBMC PDCD5 mRNA的表达上调,且随病情加重PDCD5表达增加,提示PDCD5可能通过增加其表达量而导致异常的淋巴细胞凋亡,从而参与HT的发生和发展。 Objective To explore the expression of programmed cell death 5(PDCD5) in peripheral blood monocytes(PBMC) of patients with Hashimoto's thyroiditis(HT) and to investigate their relationship.Methods 60 HT patients(HT group) admitted to Affiliated Hospital of North China Coal Medical University from March to August in 2006 and 40 healthy people(control group) at the same time were involved into the study.The HT patients were further divided into HT1 group(TMAb≤ 45%,36 cases) and HT2 group(TMAb 45%,24 cases).RT-PCR method was used to the expression of PBMC PDCD5 mRNA in HT group and control group.The function of thyroid,TGAb levels and expression of PBMC PDCD5 mRNA were compared between the HT2 group and HT2 group.Results(1) The positive expression rate and expression level of PBMC PDCD5 mRNA in HT group were both significantly higher than the control group 〔86.7%(52 /60) vs.60.0%(24 /40),(0.87 ± 0.19) vs.(0.38 ± 0.08) 〕(χ2 = 9.355,t = 4.870,P both 0.01).(2) The TGAb level and PBMC PDCD5 mRNA expression level were both significantly higher in HT2 group compared with HT1 group 〔(75.1 ± 18.9) % vs.(50.4 ± 10.7) %,(1.02 ± 0.08) vs.(0.60 ± 0.12) 〕(t = 6.400,15.041,P both 0.01).Conclusion The up-regulation of expression of PBMC PDCD5 mRNA in HT patients and the aggravation of HT suggests that abnormal apoptosis of lymphocytes led by the overexpression of PDCD5 plays an important role in the pathogenesis of HT.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第21期2480-2482,共3页 Chinese General Practice
基金 国家自然科学基金资助项目(39870427)
关键词 桥本病 程序性死亡因子5 细胞凋亡 单个核细胞 逆转录聚合酶链反应 Hashimoto disease Programmed cell death 5 Apoptosis Monouclear cells Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献3

二级参考文献13

  • 1Batteux F,Tournear L,Trebeden H.et al.Gene therapy of experimental autoimmune thyroditis by in vivo administration of plasmid DNA coding for Fas ligand[].J Immunol.1999
  • 2Runnic R,Lockwood CJ,Ma Y,et al.Expression of Fas ligand by human cytotrophoblast,implications in placentation and fetal survival[].The Journal of Clinical Endocrinology.1996
  • 3Chervonsky AV,Wang Y,Wong FS,et al.The role of Fas in autoimmune diabetes cell[].The Journal of Clinical Endocrinology.1997
  • 4Mitsiades N,Poulaki V,Kotoula V,et al.Fas/FasL ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto’s thyroiditis[].The Journal of Clinical Endocrinology.1998
  • 5Ramberger AM,Schulte HM,Thuneke I,et al.Expression of the apoptosis-inducing Fas ligand(FasL)in human first and third trimester placenta and choriocarcinoma cells[].The Journal of Clinical Endocrinology.1997
  • 6Stassi G,De Mafia R,Trucco W,et al.Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in IDDM[].The Journal of Experimental Medicine.1997
  • 7Stokes TA,Rymaszewski M,Arscott PL,et al.Constitutive expression of Fas and thyrocytes[].Science.1998
  • 8Fiedler P,Schaetzlein CE,Eibel H.Constitutive expression of Fas and thyrocytes[].Science.1998
  • 9Tanimoto C,Hirakawa S,Kawasaki H,et al.Apoptosis in thyroid disease:a histochemical study[].Endocrine Journal.1995
  • 10Lynch DH,Ramsell F,Alderson MR,et al.Fas and FasL in the homeostatic regulation of immune response[].Immunology Today.1995

共引文献30

同被引文献16

  • 1Andrikoula M., Vartholomatos G., Tsangaris G.T., Bafa M., Tzortzatou-Stathopoulou F., and Tsatsoulis A., 2001, Fas and Bcl-2 protein expression in thyrocytes of patient with nodular goiter, European Journal of Endocrinology, 145(4): 403 -407.
  • 2Chen S., Fazle Akhar S.M., Zhen Z., Luo Y., Deng L., Huang H., Chen L., and Li W., 2004, Analysis of the expression of Fas, Fast and Bcl-2 in thepathogenesis of autoimmune thwroid disorders, Cell Mol. Immunol., 1(3): 224-228.
  • 3Chen Y.Y., Sun R.H., Han W.L., Zhang Y.M., Song Q.S., Di C. H., and Ma D.L., 2001, Nuclear translocation of TFAR19 (PDCD5): An early signal for apoptosis, FEBS Letter, 509 (27): 191-196.
  • 4Hammond L.J., Lowdell M.W., Cerrano P.G., Goode A.W., Bot- tazzo G.F., and Mirakian R., 1997, Analysis of apoptosis in- relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis, J. Pathol., 182(2): 138-144.
  • 5Liu H., Wang Y., Zhang Y., Song Q., Di C., Chen G., Tang J., and Ma D., 1999, TFAR19, a novel apoptosis related gene cloned fi'om human Leukem is cell line TF-1, could en- hance apop to sis of some tumor cells induced of growth factor withdrawal, Biochem. Biophys. Res. Commun., 254 (1): 203-210.
  • 6Maruoka H., Watanabe M., Matsuzuka F., Takimoto T., Miyauchi A., and Iwatani Y., 2004, Increased intensities of fas expression on peripheral T-cell subsets in severe autoim- mune thyroid disease, Thyroid., 14(6): 417-423.
  • 7Salmaso C., Bagnasco M., Pesce G., Montagna P., Brizzolara R., Altrinetti V., Richiusa P., Galluzzo A., and Giordano C., 2002, Regulation of apoptosis in endocrine autoimmunity: Insights from Hashimoto's thyroiditis and Graves' disease, Ann. N. Y. Acad. Sci., 966(6): 496-501.
  • 8Stokes T.A., Rymaszeuski M., Arscott P.L., Wang S.H., Bretz J. D., Bartron J., and Baker J.R. Jr., 1998, Constitutive expres- sion of FasL in thyrocytes (Technical comments), Science, 279(5359): 2015.
  • 9陈占昆,吕厚山,王宁.PDCD5在类风湿关节炎成纤维样滑膜细胞凋亡中表达上调[J].中国生物化学与分子生物学报,2008,24(6):563-568. 被引量:15
  • 10余康康,刘顺爱,李文凡,沈冰,兰孟东,郎振为,成军.促凋亡因子PDCD5与Fas在肝癌及其癌旁组织中的表达[J].世界华人消化杂志,2008,16(16):1820-1824. 被引量:9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部